IJH Volume 124, Issue 3, September 2026 is now available.
IJH Volume 124, Issue 3, September 2026 is now available.
JSH members can access the full text.
-
- Targeting drug efflux and DNA repair enhances inotuzumab ozogamicin activity in IO-resistant B-ALL cell lines
- Belantamab mafodotin, bortezomib, and dexamethasone for RRMM in the Japan expansion cohort of the phase 3 DREAMM-7 trial
- Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study